LatchBio

About

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.

San Francisco,California,United States
11 - 50
https://www.latch.bio

Highlights

Details

Last Funding Type: Seed
Last Funding Money Raised: $5M
Industries: Artificial Intelligence,Bioinformatics,Biopharma,Biotechnology,Machine Learning
Founded date: Jan 1, 2021
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Latch AI Inc.
Also Known As: Latch.ai

LatchBio develops a data infrastructure intended to build and disseminate the open-source infrastructure of the biocomputing revolution. Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, the company creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery, thereby enabling biotech companies to find therapies faster and save on engineering.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$33.20M

LatchBio has raised a total of $33.20M in funding over 2 rounds. Their latest funding was raised on Jun 2, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 2, 2022	Series A	$28M	6	Coatue Lux Capital	—	Detail
Oct 1, 2021	Seed	$5M	5	Lux Capital	—	Detail
Jun 28, 2021	Pre-seed	—	1	—	—	Detail
Jan 20, 2020	Pre-seed	$200K	3	Backend Capital	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

12

LatchBio is funded by 12 investors. Coatue and Lux Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Coatue	Yes	Series A
Lux Capital	Yes	Series A
Backend Capital	Yes	Pre-seed
Caffeinated Capital	—	Series A
Fifty Years	—	Series A
Haystack	—	Series A
Hummingbird Ventures	—	Series A
General Catalyst	—	Seed
Asimov	—	Seed
Swift Ventures	—	Pre-seed